Advertising and promotion of prescription drugs, including direct-to-consumer, direct-to-patient, and professional marketing.
April 29, 2009
By:George Koroneos, Online Content & News Editor
Ortho-McNeil is reaching out to the adult ADHD segment through the popular social networking site. The plan is to grow followers through education and unbranded information. Pharm Exec takes a look at the new site.
 |
April 15, 2009
By:George Koroneos, Online Content & News Editor
Rather than ignore its aging mini-stroke medication Aggrenox, BI has shifted marketing to education by launching an unbranded site dedicated to informing sufferers about transient ischemic attacks, better known as TIA.
|
April 15, 2009
By:George Koroneos, Online Content & News Editor
After last week’s flurry of FDA warning letters directed at companies marketing through search ads, industry is left wondering what can be done be done to target patients online?
|
April 8, 2009
By:George Koroneos, Online Content & News Editor
FDA is cracking down on content in search engine advertisements. The argument is that there is a serious deficiency of risk information in the tiny link ads that appear on search ads. With pharma already wary of marketing online, will FDA’s tactic hurt future Web campaigns?
|
April 1, 2009
By:George Koroneos, Online Content & News Editor
Now that Vyvanse, Shire's innovative ADD drug, has been approved for adults, the company needs help to quickly roll out a complex message to neurologists. Its solution: a partnership that takes advantage of GSK's CNS muscle.
|
March 18, 2009
By:George Koroneos, Online Content & News Editor
Pharm Exec sits down with Kathryn Metcalfe, Pfizer's new vice president of corporate reputation and policy communications to discuss the new position, the perception of pharma among laypeople, and what needs to be done to boost public opinion of the drug industry.
|
March 4, 2009
By:George Koroneos, Online Content & News Editor
GlaxoSmithKline received a warning letter for use of misleading imagery in its television ad for Avodart. The Feds felt that comparing prostate size to planets might not be a good idea.
|
March 4, 2009
By:Brittany Agro
Manhattan Research singled out type 2 diabetes sufferers and their online search patterns; it turns out diabetes patients are less likely to confront doctors about branded drugs they?ve seen in DTC ads, yet more apt to take Lipitor.
|
| 
PharmExec Blog
Follow Us
RSS
Bookstore
